| 764048 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
906 Immunogenomic evaluation of clear cell renal carcinoma uncovers HK3 as a myeloid specific metabolic enzyme |
2021-11-01 |
10.1136/jitc-2021-sitc2021.906 |
Reinfeld Bradley, Madden Matthew, Wolf Melissa, Cubas Agi de, Haake Scott, Hongo Rachel, Axelrod Margaret, Bader Jackie, Obradovic Aleksandar, Greenwood Dalton, Ye Xiang, Balko Justin, Beckermann Katy, Vincent Benjamin, Rini Brian, Drake Charles, Rathmell Jeffrey, Rathmell W |
| 764047 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
905 FASN prevents immunogenicity of irradiated glioblastoma by inhibiting ER stress |
2021-11-01 |
10.1136/jitc-2021-sitc2021.905 |
Martino Mara De, Daviaud Camille, Vanpouille-Box Claire |
| 764046 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
904 Repurposing CD26 (DPP4) inhibitors to enhance immunotherapy response in pancreatic ductal adenocarcinoma |
2021-11-01 |
10.1136/jitc-2021-sitc2021.904 |
Phillips Maggie, Ware Michael, Herting Cameron, Mace Thomas, Maithel Shishir, Sarmiento Juan, El-Rayes Bassel, Paulos Chrystal, Wyatt Megan, Lesinski Gregory |
| 764045 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
902 Comprehensive multi-omics meta-analysis of pancreatic cancer mouse models and human PDAC data sets identifies unique cancer-associated fibroblast subsets |
2021-11-01 |
10.1136/jitc-2021-sitc2021.902 |
Wai Sze Lei Candace, Holt John, Flynn Brianna, Barrett Richard, Budhani Pratha, Kamalakannan Mohanapriya, Wasti Ruby, Thiede Lucinda, Tagore Joshua, Potts Jessica, Larouche Jacqueline, Marcher Marie, Liao Xiaoyun, O’Brien Sarah, Kashyap Abhishek, Pignatelli Jeanine, Liu Kang, Tumang Joseph, Corse Emily, Stanger Ben, Pure Ellen, Rodriguez DiBlasi Varenka |
| 764044 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
899 Population coverage of HLA-A*02:01, *02:05, *02:06 across selected cancer types in the United States |
2021-11-01 |
10.1136/jitc-2021-sitc2021.899 |
Patel Nashita, Carroll Charlotte, Culver Ken, Pokras Shibani |
| 764043 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
898 Intratumoral administration of NL-201, an alpha-independent IL-2/15 receptor agonist, inhibits the growth of both injected and uninjected tumors in preclinical models |
2021-11-01 |
10.1136/jitc-2021-sitc2021.898 |
Tatalick Laurie, Yu Kevin, Huard Justin, Huard Justin, Riley Marianne, Swanson Ryan, Walkey Carl |
| 764042 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
243 Understanding and overcoming the mechanism of resistance to anti-PD-1 monotherapy in brain metastasis |
2021-11-01 |
10.1136/jitc-2021-sitc2021.243 |
Font Laura Falceto, Flores Catherine, Figg Jack, Dean Bayli DiVita, Francis Connor, Kuizon Carmelle, Moore Ginger |
| 764041 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
169 Off-the-shelf, engineered iPSC-derived NK cells mediate potent cytotoxic activity against primary glioblastoma cells and promote durable long-term survival in vivo |
2021-11-01 |
10.1136/jitc-2021-sitc2021.169 |
Cichocki Frank, Ning Jianfang, Davis Zachary, Wang Hongbo, Tuininga Katie, Bjordahl Ryan, Rogers Paul, Ge Moyar, Lee Tom, Valamehr Bob, Chen Clark, Miller Jeffrey |
| 764040 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
92 Single cell and spatial multiplex profiling of immune cell markers in FFPE tumor tissues using the novel RNAscope™ HiPlex v2 in situ hybridization assay |
2021-11-01 |
10.1136/jitc-2021-sitc2021.092 |
Basak Sayantani, Dikshit Anushka, Yu Ming, Ji HaYeun, Chang Ching-Wei, Zhang Bingqing |
| 764039 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
590 Anti-CD33 actinium-225 targeted radioimmunotherapy enhances the biologic activity of anti-CD47 antibody immunotherapy in preclinical models of acute myeloid leukemia |
2021-11-01 |
10.1136/jitc-2021-sitc2021.590 |
Pachhal Sagarika, Greer Emily, Hwang Jesse, Liang Qing, Chen Mary, Geoghegan Eileen, Kotanides Helen, Ludwig Dale, Beckford Denis |
